title: [Patient education for self-management of oral anticoagulation - situation in Hesse].
abstract: OBJECTIVE
  Oral anticoagulation (OAC) has been shown to be highly effective in preventing thromboembolic complications. Self-management can enable patients with a long-term indication for OAC to be actively involved in the therapy, but in Germany the implementation of self-management is linked to mandatory training. To illustrate significant structural disparities between education centres in Hesse, all such centres were identified and a list generated, specifying the differences.
  
  
  METHODS
  Using our own questionnaire, we interviewed all known patient education centres in Hesse between January and July 2012, and conducted a descriptive analysis of their structural features.
  
  
  RESULTS
  There were 44 datasets for statistical interpretation. We distinguished between centres with ASA certification (n=19) and centres without (n=25). On average, certified centres provide 6 h of training (range 2-9) compared to 5.5 h (range 1-12) in uncertified centers. Certified centres hold more group sessions per year (on average 17 vs. 8) and more individual training sessions (on average 10 vs. 5). Certified centres train 10-365 patients per year and uncertified centers between 5 and 77. Certified centres offer retraining more frequently (84% vs. 40%) and more often conclude the training with a written test (74% vs. 44%). Only 9 centres provide materials for patients with a migration background.
  
  
  CONCLUSIONS
  The results show that in Hesse, severe structural discrepancies exist in training programmes for self-management of OAC, and it can be assumed that patients participating in trainings in different Hessian education centres face very differing conditions. To improve the quality of the trainings and to ensure patients have similar levels of knowledge, it is imperative that centres be regularly inspected with the help of proven quality indicators.
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Hirschfeld
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Mergenthal
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: J J
authors.initials: JJ
authors.lastname: Petersen
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Rauck
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Roehl
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: L-R
authors.initials: LR
authors.lastname: Ulrich
authors.affiliation: Goethe Universität Frankfurt am Main, Institut für Allgemeinmedizin, Frankfurt am Main, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Siebenhofer
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D003479:Curriculum / Q000706:statistics & numerical data*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D010353:Patient Education as Topic / Q000379:methods* / Q000706:statistics & numerical data*; D012646:Self Administration / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D013923:Thromboembolism / Q000453:epidemiology* / Q000517:prevention & control*; D016903:Drug Monitoring
chemical_list: D000925:Anticoagulants